Myriad Genetics MYGN Q1 2025 earnings
Reported May 6, 2025 · After market close
Revenue$195.9MMiss by $15.8M
EPS-$0.03Beat by $0.02
Revenue estimate$211.7M
EPS estimate-$0.05
Next report
Jul 30, 2026 (Tomorrow)Revenue estimate$206.0M
EPS estimate-$0.03
Financials
Q1 2025Valuation & ratios
Versus estimates
Revenue
Diluted EPS
Ask the moment Myriad Genetics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Myriad Genetics report Q1 2025 earnings?
- Myriad Genetics (MYGN) reported Q1 2025 earnings on May 6, 2025 after market close.
- What were Myriad Genetics's Q1 2025 revenue and EPS?
- Myriad Genetics reported revenue of $195.9M and eps of $-0.03 for Q1 2025.
- Did Myriad Genetics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $211.7M by $15.8M. EPS beat the consensus estimate of $-0.05 by $0.02.
- How did Myriad Genetics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 3.1% from $202.2M a year earlier and eps declined 200.0% from $-0.01.
- Where can I find Myriad Genetics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000899923-25-000048) directly on SEC EDGAR. The filing index links above go to sec.gov.